Gregory Engel
Directeur/Bestuurslid bij Canadian Chamber of Commerce
Actieve functies van Gregory Engel
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Canadian Chamber of Commerce
Canadian Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Canadian Chamber of Commerce is a chamber of commerce organization. The non-profit company is based in Ottawa, Canada. | Directeur/Bestuurslid | 30-10-2020 | - |
Clairvoyant Therapeutics, Inc.
Clairvoyant Therapeutics, Inc. BiotechnologyHealth Technology Part of Origin Therapeutics Holdings, Inc., Clairvoyant Therapeutics, Inc. is a Canadian biotechnology company focused on mental health through psilocybin therapy. The company is based in Vancouver, Canada. Clairvoyant is changing the face of psychedelic therapy with a speed-to-market clinical strategy designed to enable psilocybin therapy in the US, the EU, and to treat patients living with alcohol use disorder (AUD) beginning in 2026. Clairvoyant's exceptional team, with a proven clinical track record and deep drug development experience, has made it the most advanced company developing psilocybin therapy for the treatment of AUD. Clairvoyant was founded by Damian Kettlewell, Thomas Digby, and has been led by Damian Kettlewell as CEO since incorporation. Clairvoyant Therapeutics was acquired by Origin Therapeutics Holdings, Inc. on July 07, 2022. | Directeur/Bestuurslid | - | - |
Loopbaan van Gregory Engel
Eerdere bekende functies van Gregory Engel
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ORGANIGRAM HOLDINGS INC. | Directeur/Bestuurslid | 13-03-2017 | 03-05-2021 |
Algemeen Directeur | 13-03-2017 | 03-05-2021 | |
Tilray Canada Ltd.
Tilray Canada Ltd. Pharmaceuticals: OtherHealth Technology Tilray Canada Ltd. provides ship medical cannabis to registered patients. The firm offers research and health policy, microbiology, plant genetics and drug development. The company is headquartered in Nanaimo, Canada. | Algemeen Directeur | 01-01-2015 | 01-06-2016 |
Forest Laboratories Canada, Inc.
Forest Laboratories Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Forest Laboratories Canada, Inc. is a pharmaceutical company based in Saint John, Canada. | Corporate Officer/Principal | 01-11-2010 | 01-08-2014 |
Opleiding van Gregory Engel
University of Guelph | Undergraduate Degree |
Statistieken
Internationaal
Canada | 7 |
Operationeel
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ORGANIGRAM HOLDINGS INC. | Process Industries |
Bedrijven in privébezit | 4 |
---|---|
Canadian Chamber of Commerce
Canadian Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Canadian Chamber of Commerce is a chamber of commerce organization. The non-profit company is based in Ottawa, Canada. | Commercial Services |
Forest Laboratories Canada, Inc.
Forest Laboratories Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Forest Laboratories Canada, Inc. is a pharmaceutical company based in Saint John, Canada. | Health Technology |
Tilray Canada Ltd.
Tilray Canada Ltd. Pharmaceuticals: OtherHealth Technology Tilray Canada Ltd. provides ship medical cannabis to registered patients. The firm offers research and health policy, microbiology, plant genetics and drug development. The company is headquartered in Nanaimo, Canada. | Health Technology |
Clairvoyant Therapeutics, Inc.
Clairvoyant Therapeutics, Inc. BiotechnologyHealth Technology Part of Origin Therapeutics Holdings, Inc., Clairvoyant Therapeutics, Inc. is a Canadian biotechnology company focused on mental health through psilocybin therapy. The company is based in Vancouver, Canada. Clairvoyant is changing the face of psychedelic therapy with a speed-to-market clinical strategy designed to enable psilocybin therapy in the US, the EU, and to treat patients living with alcohol use disorder (AUD) beginning in 2026. Clairvoyant's exceptional team, with a proven clinical track record and deep drug development experience, has made it the most advanced company developing psilocybin therapy for the treatment of AUD. Clairvoyant was founded by Damian Kettlewell, Thomas Digby, and has been led by Damian Kettlewell as CEO since incorporation. Clairvoyant Therapeutics was acquired by Origin Therapeutics Holdings, Inc. on July 07, 2022. | Health Technology |
- Beurs
- Insiders
- Gregory Engel
- Ervaring